Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HRS7535 in type 2 diabetic kidney disease
CTR20241703Phase 2Completed
- Sponsor
- Shandong Sende
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7535 in diabetic glomerulosclerosis, type 2 diabetes mellitus (T2DM), sponsored by Shandong Sende. Started May 2024; status: completed.
02
Drugs
HRS-7535
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20241703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241703.